Time to complete:
5 minutes
Date of publication:
March 2020

This screencast looks primarily at the newer insulins – insulin analogues – and where they fit in in the management of type 2 diabetes. The initiation and adjustment of insulin in type 2 diabetes is also discussed, along with the role of flash glucose monitoring in glycaemic control.

An educational grant was received by Novo Nordisk for the production of the screencast. Editorial and content decisions were made solely by the RCGP. 

Novo Nordisk